Tor2 Activators

Tor2 Activators, as a class of chemicals, share the common trait of being able to activate the Tor2 protein, either directly or through influencing related signaling pathways. The Tor2 protein is involved in several cellular processes such as cell growth and autophagy. Activation of Tor2 can therefore have significant effects on these processes. Rapamycin, for instance, binds with FKBP12 to form a complex that mimics the inactivated state of Tor2, thus indirectly activating the protein. Similarly, nicotinamide and resveratrol act on the SIRT1 protein, which has a regulatory effect on Tor2. Nicotinamide inhibits SIRT1, leading to an increase in Tor2 activity, while Resveratrol activates SIRT1, which then inhibits negative regulators of the Tor2 pathway.

Conversely, some chemicals like metformin, aminoimidazole carboxamide, berberine, and curcumin target the Tor2 pathway indirectly via the AMP-activated protein kinase (AMPK). Metformin, for instance, reduces ATP production, leading to an increase in AMP levels and subsequent activation of AMPK and Tor2. Similarly, aminoimidazole carboxamide and berberine can activate AMPK, which in turn activates Tor2. Several Tor2 activators, such as quercetin, curcumin, and epigallocatechin gallate, function by inhibiting negative regulators of Tor2, thereby allowing for increased Tor2 activity. For instance, both curcumin and epigallocatechin gallate can inhibit mTOR, a negative regulator of Tor2, leading to increased Tor2 activity. Quercetin inhibits the phosphatidylinositol 3-kinase, another negative regulator of Tor2.